-
How To Create Loyal Customers Not Because They Don't Have Other Options, But Because They Do
Thursday, June 1, 2023 - 12:15pm | 787Marijuana’s status as a Schedule 1 substance under federal law makes things far more complicated for this industry compared to others. Despite 23 states having legalized recreational cannabis use and 39 with medical marijuana programs, one of the biggest challenges to the...
-
MariMed Reports Earnings: Q1 Revenue Falls 4% Sequentially, CEO Pleased With 'Solid Quarter'
Monday, May 8, 2023 - 8:02pm | 434MariMed, Inc (CSE: MRMD) (OTCQX: MRMD) announced its financial results late Monday for the first quarter ended March 31, 2023. “I am pleased to report another solid quarter,” said CEO Jon Levine. “We reported our 13th consecutive quarter of positive adjusted EBITDA, and we...
-
EXCLUSIVE: 'Beat The Crap Out Of The Competition' And Other Cannabis Industry Secrets To Success
Monday, April 24, 2023 - 8:39am | 767The marijuana industry continues to face challenges with restricted financing options. But several titans in the space gathered on stage at the 2023 Benzinga Cannabis Capital Conference in Miami to offer suggestions on how to maintain growth. One of the panelists included David Traylor,...
-
Interested In Cannabis Industry Growth Trends? CEO Of Weed Distribution Giant Eaze Has Some Insights
Tuesday, March 21, 2023 - 9:32am | 610The Benzinga Cannabis Capital Conference, the world's largest gathering of cannabis decision-makers, founders, investors and advocates is returning to Miami Beach, Florida on April 11-12, 2023 and Eaze's CEO Cory Azzalino will be there to share his insights into where industry...
-
Latest Executive Changes In Marijuana Industry, New Appointments & More
Friday, March 3, 2023 - 4:25pm | 666As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the marijuana industry, let's scroll through the latest leadership changes in the space. Meet MariMed's New Chairman And CEO Cannabis multi-state operator MariMed, Inc. (...
-
2023 Off To A Busy Start: Top Cannabis Execs Making Moves, Will They Attend Benzinga's April Event?
Thursday, March 2, 2023 - 1:37pm | 1314As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the marijuana industry, let's scroll through some executive moves from the first two months of 2023. Humble & Fume's New CEO Starting off with Humble & Fume...
-
Acquisitions & Expansion Boost Marimed's Q4 Revenue 6% Sequentially, 2022 Sales Increased To $134M
Wednesday, March 1, 2023 - 9:56pm | 551MariMed, Inc. (OTCQX: MRMD) announced its financial results Wednesday afternoon for the fourth quarter and full year ended December 31, 2022. The company reported sales for the year increased to $134 million, compared with $121.5 million the prior year. Net income nearly doubled to $13.5...
-
Key Marijuana Executive Changes You Should Know About: Award-Winning TV Personality Joins MMJ Start-Up & More News
Tuesday, January 31, 2023 - 12:51pm | 883As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the cannabis industry, let's scroll through the latest leadership changes within the space. Emmy Award-Winning TV Personality Joins Cannformatics' Advisory...
-
Cannabis Company MariMed Closes $35M Credit Facility To Boost Strategic Growth Plans
Tuesday, January 24, 2023 - 9:32pm | 624MariMed, Inc. (OTCQX: MRMD), a leading multi-state cannabis operator, announced it closed a $35 million secured credit facility with Chicago Atlantic Advisors, LLC as the lead lender. "I am delighted to announce the closing of this transformative credit facility (...) MariMed is known for...
-
Key Marijuana Executive Changes: Who Will Lead MariMed After CEO's Passing? MJBiz CEO Steps Down
Monday, December 19, 2022 - 1:45pm | 989MJBiz CEO To Step Down Marijuana Business Daily's Chris Walsh will step down as CEO in January. The move comes nearly a year after Denver-based cannabis publishing and trade show business was acquired by Emerald X, a wholly owned subsidiary of Emerald Holding, Inc. (NYSE: EEX) for $...
-
MariMed's Q3 Financial Results, Revenue Increases 3% Sequentially To $33.9M
Monday, November 7, 2022 - 7:49pm | 813MariMed, Inc. (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, recently announced its financial results for the third quarter that ended September 30, 2022. Financial Highlights The following table “summarizes the consolidated financial...
-
EXCLUSIVE: How To Conquer The Midwest? 4Front, Pharmacann & Marimed Execs Discuss At Benzinga Cannabis Conference
Wednesday, September 14, 2022 - 3:40pm | 807Jon Levine, president of Marimed Inc., Brett Novey, CEO of Pharmacann and Andrew Thut, CIO of 4Front Ventures, operators in the Midwest and across the country, joined Barbara Webb, partner of MGO, and Steve Miles, CEO of Sharp Capital Advisors in a panel at Benzinga’s Cannabis Capital...
-
MariMed Appoints Jon Levine As President
Wednesday, September 7, 2022 - 10:05am | 418MariMed, Inc. (CSE:MRMD), (OTCQX: MRMD) appointed Jon Levine as president. “I am thrilled to announce Jon’s appointment as president of the company, a role that includes his continued oversight of the day-to-day management of the company,” stated MariMed CEO Bob Fireman. “...
-
MariMed Reports Strong Q1, Provides 2022 Financial Guidance
Wednesday, May 11, 2022 - 9:02am | 504MariMed, Inc. (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the first quarter ended March 31, 2022. “I am very pleased with our solid financial results this past quarter despite a slowdown in our industry...
-
EXCLUSIVE: Lessons Learned At The Benzinga 2022 Psychedelics And Cannabis Capital Conferences
Wednesday, April 27, 2022 - 4:15pm | 1464Benzinga, a large content provider to brokerages and news outlets, hosts live conferences to recognize disruptive innovation in finance and technology, trading, and emerging assets. Two of those events – Benzinga’s Psychedelics and Cannabis Capital conferences – happened last week...